Glenmark Pharmaceuticals (India)
In research, Glenmark Pharmaceuticals (India) stands highest in Health Sciences (#17,377 of 20,462 worldwide) and Medicine (#16,584 of 17,978 worldwide), over all time.
- World rank, 2022–2025
- #23,506 of 28,054 · #28,307 all time
- Rank in India
- #1,559 of 1,840
- Research works
- 298 ▲ 47% vs 2013–17
- Citations
- 3.8k 12.8 per fractional work
- Top-10% rate
- 4.5% record average 16.5%
- Open access
- 52% world 28%
What is Glenmark Pharmaceuticals (India) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #17,377 of 20,462 | 6.0% | 180 | |
| MedicineField | #16,584 of 17,978 | 6.0% | 174 |
Each strip is that field’s whole ranked pool, with the notch where Glenmark Pharmaceuticals (India) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.1×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 10.1×
- Immunology and Microbiology 4.3×
- Medicine 3.6×
- Biochemistry, Genetics and Molecular Biology 1.8×
- Decision Sciences 1.7×
- Chemistry 1.2×
- Nursing 1.1×
- Economics, Econometrics and Finance 0.8×
- Dentistry 0.8×
- Health Professions 0.7×
- Mathematics 0.7×
- Neuroscience 0.5×
- Materials Science 0.2×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Psychology 0.0×
- Social Sciences 0.0×
Who are the top researchers at Glenmark Pharmaceuticals (India)?
Ranked on the composite score, Bharat Dalvi, Hanmant Barkate and Anish Desai lead among researchers whose main affiliation is Glenmark Pharmaceuticals (India).
- 1 Bharat Dalvi India · #919,377 worldwide 18 citations · 29 works
- 2 Hanmant Barkate India · #1,175,765 worldwide 15 citations · 15 works
- 3 Anish Desai India · #1,468,297 worldwide 11 citations · 16 works
- 4 Krupa Krishnaprasad India · #1,481,606 worldwide 12 citations · 29 works
- 5 Saiprasad Patil India · #1,588,191 worldwide 4 citations · 16 works
Which keywords describe research at Glenmark Pharmaceuticals (India)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Glycemic Control, Insulin Therapy, Diagnosis, Treatment, Clinical Guidelines, Heart Failure and Asthma.
- COPD
- Onychomycosis
- Cancer Risk
- Tumor Microenvironment
- Autoantibodies
- Cough Reflex Sensitivity
- Type 1 Diabetes
- Global Burden
- Complications
- Nanoparticles
- Eosinophils
- Allergic Diseases
- Antifungal Therapy
- Glucose Control
- Cardiovascular Outcomes
- Asthma
- Cardiovascular Disease
- Treatment
- Inflammation
- Glycemic Control
- Epidemiology
- Insulin Therapy
- Diagnosis
- Clinical Guidelines
- Heart Failure
- Quality of Life
- Genetics
- Type 2 Diabetes
- Management
- Diabetes
- Immunology
- Cancer Therapy
- Continuous Glucose Monitoring
- Hypoglycemia
- Chronic Cough
- Diabetes Mellitus
- Autoimmune
- Antibiotic Resistance
- Dermatophytes
- Monoclonal Antibodies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology11▲ 4.5×20 topics
- Glycemic Control6▲ 62×3 topics
- Insulin Therapy6▲ 79×3 topics
- Inflammation6▲ 4.2×14 topics
- Diagnosis5▲ 8.9×8 topics
- Treatment5▲ 6.7×9 topics
- Clinical Guidelines5▲ 26×4 topics
- Cardiovascular Disease4▲ 6.5×8 topics
- Heart Failure4▲ 17×6 topics
- Asthma4▲ 68×2 topics
- Quality of Life3▲ 3.8×9 topics
- Cardiovascular Outcomes3▲ 97×1 topic
- Genetics3▲ 7.6×6 topics
- Glucose Control3▲ 97×1 topic
- Type 2 Diabetes3▲ 24×2 topics
- Antifungal Therapy3▲ 56×3 topics
- Management3▲ 6.4×6 topics
- Allergic Diseases3▲ 79×1 topic
- Diabetes3▲ 9.5×4 topics
- Eosinophils3▲ 79×1 topic
- Immunology3▲ 44×2 topics
- Nanoparticles2▲ 3.2×4 topics
- Cancer Therapy2▲ 6.5×7 topics
- Complications2▲ 7.3×2 topics
- Continuous Glucose Monitoring2▲ 78×1 topic
- Global Burden2▲ 7.0×2 topics
- Hypoglycemia2▲ 78×1 topic
- Type 1 Diabetes2▲ 43×2 topics
- Chronic Cough2▲ 134×1 topic
- Cough Reflex Sensitivity2▲ 134×1 topic
- Diabetes Mellitus2▲ 15×5 topics
- Autoantibodies2▲ 12×3 topics
- Autoimmune2▲ 56×2 topics
- Tumor Microenvironment2▲ 6.0×2 topics
- Antibiotic Resistance2▲ 6.8×4 topics
- Cancer Risk2▲ 12×2 topics
- Dermatophytes2▲ 103×1 topic
- Onychomycosis2▲ 103×1 topic
- Monoclonal Antibodies2▲ 28×3 topics
- COPD1▲ 34×1 topic
Which research topics does Glenmark Pharmaceuticals (India) publish most on?
By volume in 2022–2025: Diabetes Treatment and Management, Asthma and respiratory diseases, Diabetes Management and Research and Respiratory and Cough-Related Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 3 works
- 2 Asthma and respiratory diseases Physiology 3 works
- 3 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 2 works
- 4 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 2 works
- 5 Nail Diseases and Treatments Epidemiology 2 works
- 6 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
- 7 Antifungal resistance and susceptibility Infectious Diseases 1 works
- 8 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 1 works
- 9 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 10 Allergic Rhinitis and Sensitization Immunology and Allergy 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Glenmark Pharmaceuticals (India)'s research output changed?
Output in 2018–2022 was 47% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mumbai
- Indian Institute of Technology Bombay
- Bhabha Atomic Research Centre
- Tata Institute of Fundamental Research
- University of Mumbai
- Institute of Chemical Technology
- Homi Bhabha National Institute
- Tata Memorial Hospital
- Narsee Monjee Institute of Management Studies
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.